The verified answer
As of Sep 2026, DEPLOY verifies Merck KGaA: 1 model. 1 source back the record.
Deploy Watch
Track Merck KGaA on Deploy.
We notify you when a verified state change lands on the record, not when the company issues a claim.
Regional ecosystem
Merck KGaA is one of 175 verified robotics companies in Germany →
Key facts
HQ
Focus
Stage
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Partnerships
Every company Merck KGaA has built with, alongside the ones only announced in a press release.
Most-frequent partners
- 1Microsoft1× joint350 total
Most recent
Merck KGaA on the deployment map
View the global mapMerck KGaA has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for Merck KGaA on the DEPLOY record yet. Track Merck KGaA to know the moment the first one is verified.
Relationships
Current leadership (1)
- Kai Beckmann CEOsecondary-verified
Safety record
No incidents on record for Merck KGaA.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Merck KGaA in third-party press
ICR Scientists Develop Pathfinder Molecules Targeting DHX8 in Cancer Drug Discovery
Merck KGaA inks $11B Bio-Techne buyout to expand into cell therapy production - BioSpace
Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion - Pharmaceutical Technology
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- mature
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships
1 total · 1 operating
Every company Merck KGaA has built with, alongside the ones only announced in a press release.
Most recent
Most-frequent partners
- 1Microsoft1× joint350 total
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 8, 2026
Added to the verified registry
Sources (1)
Common questions
What is Merck KGaA?
What does Merck KGaA make?
Is Merck KGaA publicly traded?
Who is the CEO of Merck KGaA?
How can I invest in Merck KGaA?
Where is Merck KGaA headquartered?
Who owns Merck KGaA?
Where does Merck KGaA operate robots?
Is Merck KGaA a top robotics company?
Is Merck KGaA safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Merck KGaA.In the press
Recent coverage mentioning Merck KGaA from third-party publications. Automatically surfaced; not part of the verified registry record.
ICR Scientists Develop Pathfinder Molecules Targeting DHX8 in Cancer Drug Discovery
(IN BRIEF) Researchers at The Institute of Cancer Research, London, working with Merck KGaA, have developed the first potent small-molecule inhibitors of DHX8, an enzyme involved…
Merck KGaA inks $11B Bio-Techne buyout to expand into cell therapy production - BioSpace
<a…
Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion - Pharmaceutical Technology
<a…
MilliporeSigma's CTO on AI retrosynthesis, the Merck KGaA–Siemens deal and the chemistry that runs the autonomous lab - R&D World
<a…
Merck KGaA (MRK) Predicts Slightly Better Profit as New CEO Takes Over - Bloomberg.com
<a…
Merck KGaA Reduced Cooling Energy by 21% Through AI Use - PharmTech.com
<a…
Bioprocess 5.0: Straddles the Human-AI Divide to Scale Next-Gen Therapies - Genetic Engineering and Biotechnology News
<a…
Merck KGaA Drops up to $2B in Skyhawk Collab for RNA-Targeting Tech - BioSpace
<a…
Self-driving cars are hitting the streets. Is your lab up next for automation? - R&D World
<a…
Merck Launches AAW™ Workstation to Advance Lab Automation - Merck Group
<a…
ASCO25: Merck KGaA’s ADC shows safety and tolerability in colorectal cancer trial - Clinical Trials Arena
<a…
ASCO25: Merck KGaA to seek approval of TGCT drug after Phase III success - Clinical Trials Arena
<a…
Machine-readable surfaces
- Markdown mirror: /companies/merck-kgaa.md
- RSS feed: /companies/merck-kgaa/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/b7bcfab5-5873-4def-9e83-a7c0844c6128
- Revision history: /companies/merck-kgaa/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Heat Index
Serious52/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Merck KGaA draws attention at the 63rd percentile but verifies reality at the insufficient-data level among other robots.
6-month trend
Analysis
Limited public funding data for capital position assessment.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 20, 2026